Moleac is a biopharmaceutical company headquartered in Singapore since 2002, focusing on Neurology.

Our flagship product, NeuroAiD, is designed for post-stroke recovery and is based on traditional medicine. It is marketed in over 30 countries across Asia, the Middle East, Europe, and Africa, experiencing rapid growth and becoming the focus of numerous scientific research projects and clinical trials. In 2021, NeuroAiD was used by an estimated 40,000 individuals.

Moleac has grown through a partnership approach, working with internationally renowned academic centers for research, high-quality contract manufacturers, and exclusive commercial partners in each market. We have ambitious plans for new product launches starting from 2022 onwards.

The international commercial team is responsible for establishing and growing international sales of NeuroAiD. This includes identifying and partnering with local players to build market presence and operations. Each Key Acc...